George D. Dangas, MD, PhD — Columbia University Medical Center, Cardiovascular Research Foundation
Faculty Disclosure
Nothing to Disclose
Learning Objectives
- Mechanism of action, differences from heparin
- Comparison between agents, safety and efficacy considerations
- Clinical results from use of bivalirudin in PCI and ACS
- Future directions